Harvest Fund Management Co. Ltd Invests in Astera Labs, Inc.

Harvest Fund Management Co. Ltd has taken a significant step by acquiring a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the fourth quarter, as per the latest 13F filing with the Securities and Exchange Commission. The investment firm bought 4,766 shares of Astera Labs, with an estimated value of approximately $629,000.

Other institutional investors and hedge funds have also adjusted their positions in Astera Labs recently. For example, CIBC Asset Management Inc made a new investment in the firm during the third quarter, worth about $237,000. Likewise, Avior Wealth Management LLC and First Horizon Advisors Inc reported new stakes valued at approximately $361,000 and $49,000, respectively.

Massachusetts Financial Services' Significant Stake

Massachusetts Financial Services Co. MA notably expanded its investment in Astera Labs by 253.4% during the third quarter. After acquiring an additional 231,585 shares, its total holdings now amount to 322,993 shares, valued at about $16,922,000. Additionally, Westfield Capital Management Co. LP purchased new shares valued at around $52,049,000. Notably, institutional investors currently hold 60.47% of the company's stock.

Astera Labs Stock Overview

As of Friday, shares of NASDAQ ALAB opened at $68.97. The firm has a market capitalization of $11.18 billion, a 50-day simple moving average of $92.41, and a 200-day simple moving average of $88.70. Over the past year, Astera Labs' stock has experienced a low of $36.22 and a high of $147.39.

Recent Earnings Report

In another development, Astera Labs reported its quarterly earnings on February 10, indicating an earnings per share (EPS) of $0.10. This figure fell short of analysts' expectations of $0.26 by $0.16. The company has faced challenges, reflected in its negative net margin of 21.05% and a negative return on equity of 10.40%. Analysts predict that Astera Labs will record an EPS of 0.34 in the current fiscal year.

Insider Activity

In recent insider trades, General Counsel Philip Mazzara sold 7,536 shares of Astera Labs on February 18, receiving an average price of $92.07, which totaled approximately $693,839.52. After the transaction, Mazzara retained ownership of 241,209 shares, valued at around $22,208,112.63, marking a 3.03% decrease in his position. CFO Michael Truett Tate also sold a significant number of shares—125,800 at an average price of $82.53—totaling about $10,382,274.00, resulting in a 34.00% reduction in his holdings. In the past 90 days, insiders have collectively sold shares worth $50,242,702.

Analyst Ratings

Astera Labs has garnered attention from various equities research analysts. Raymond James initiated coverage on the stock, giving it an “outperform” rating with a price target of $82.00. Northland Capmk upgraded its rating from “hold” to “strong-buy,” while Barclays increased their price target from $87.00 to $135.00, designating the stock as “overweight.” Many analysts remain optimistic, with one hold rating, twelve buy ratings, and one strong buy designation. The general consensus rating for the stock is “Buy” with a consensus price target of $112.77.

Company Profile

Astera Labs, Inc. specializes in designing, manufacturing, and selling semiconductor-based connectivity solutions tailored for cloud and AI infrastructure. The company's Intelligent Connectivity Platform comprises a range of high-performance data, network, and memory connectivity products, built using a software-defined architecture that empowers customers to deploy large-scale cloud and AI operations.

investment, stocks, funds